| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1050-1738(02)00210-4 |
| P698 | PubMed publication ID | 12554099 |
| P2093 | author name string | Amy E Schmidt | |
| S Paul Bajaj | |||
| P433 | issue | 1 | |
| P304 | page(s) | 39-45 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Trends in Cardiovascular Medicine | Q1850265 |
| P1476 | title | Structure-function relationships in factor IX and factor IXa. | |
| P478 | volume | 13 |
| Q92007848 | A new in silico approach to investigate molecular aspects of factor IX missense causative mutations and their impact on the hemophilia B severity |
| Q39539762 | A plasma proteolysis pathway comprising blood coagulation proteases |
| Q30429771 | An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B. |
| Q37919102 | Aptamers as therapeutics in cardiovascular diseases |
| Q33389174 | Aptamers: the emerging class of future anticoagulation for vascular disease |
| Q36229226 | Construction of the pIRES2-ZsGreen1 eukaryotic expression vector of Factor Ⅸ gene and expression in HEK-293 cells |
| Q44422886 | Contribution of Basic Residues of the Autolysis Loop to the Substrate and Inhibitor Specificity of Factor IXa |
| Q64960028 | Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase. |
| Q34115814 | Correlation of factor IXa subsite modulations with effects on substrate discrimination |
| Q36884329 | Exosites in the substrate specificity of blood coagulation reactions |
| Q51037137 | Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. |
| Q37363970 | Functional role of O-linked and N-linked glycosylation sites present on the activation peptide of factor X. |
| Q37789715 | Gene therapy strategies for hemophilia: benefits versus risks |
| Q50049635 | Investigation of O-glycosylation heterogeneity of recombinant coagulation factor IX using LC-MS/MS. |
| Q89776548 | Plasmin-mediated proteolysis of human factor IXa in the presence of calcium/phospholipid: Conversion of procoagulant factor IXa to a fibrinolytic enhancer |
| Q39154043 | Recent advances in hemophilia B therapy |
| Q41998414 | Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium |
| Q34095400 | Structure and function of factor XI |
| Q39850743 | Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions |
| Q46220531 | The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex |
| Q37872258 | Therapeutic plasma proteins--application of proteomics in process optimization, validation, and analysis of the final product |
| Q37318613 | Update on the physiology and pathology of factor IX activation by factor XIa. |
Search more.